Company
Optimeos Life Sciences, Inc.
| Industry | company developing a proprietary nanoparticle platform for the intracellular delivery of therapeutic macromolecules, including RNA, DNA and proteins |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Optimeos Life Sciences, Inc. | Investment | 2026-06-25 |